Health & Education · Bucharest and Brussels

Romanian health minister denies Lyrica shortage as journalist and ex-minister dispute it

Health Minister Alexandru Rogobete said on Sunday, 15 November, that 2,352,445 units of pregabalin medicines were in stock as of 13 November, and a former minister accused him of lying on Monday, 16 November.

AI text based on reports by Ziare.com, G4Media.ro, adevarul.ro and other publishers. Published . How it is made

For membersThe first 30 seconds for everyone. Synthetic voice (AI).

In brief

Bucharest, Brussels · Romania, Belgium

A journalist's post and the minister's reply

On Sunday, 15 November 2026, Digi24 journalist Liliana Ruse wrote on Facebook that Lyrica, which she said helps ease the numbness in her hands and feet caused by chemotherapy, had disappeared from the market. She said generic versions were also unavailable and called the Romanian state criminal. Ruse, who is undergoing cancer treatment, wrote that she would not spell out what the shortage of antidepressants means for patients with psychiatric problems.

The same day, Health Minister Alexandru Rogobete replied on Facebook without naming her, calling the claim that Lyrica and generics with the same active substance had vanished from Romania's market untrue. Ruse answered by revising her own post. She said the minister was making her practically crazy and offered to pay for a box in Bucharest, then wrote:

“Lyrica can be found, it is in stock, it has not disappeared.”

Liliana Ruse

Stock figures and the ministry's position

Rogobete cited data reported on 13 November 2026, which showed 922,627 units of medicines containing pregabalin in distributor stocks and 1,429,818 units in community pharmacies. Taken together, the national total was 2,352,445 units, covering both the original Lyrica and its generic versions. He conceded that a medicine may be unavailable at a given pharmacy at a given time, but argued that this does not mean it has left the national market. Pharmacists who commented on the minister's post confirmed a major shortage of the substance, and other commenters said they had hit the same problem.

Pregabalin medicine units reported on 13 November 2026units
Distributor stocks
922627 units
Community pharmacies
1429818 units
Total
2352445 units

Data from the article text

Former ministers and the agency's notices

Vlad Voiculescu, a USR member of the European Parliament and honorary presidential adviser, accused Rogobete of lying on Monday, 16 November, after the minister said no shortage of oncology medicines such as Lyrica existed. Voiculescu pointed to the National Medicines Agency's website, which he said carries official notices of temporary discontinuation:

“On the website of the National Medicines Agency itself there are official notices of temporary discontinuation for Lyrica 150 mg, starting June 2026, and Lyrica 75 mg, starting November 2026.”

Vlad Voiculescu, USR member of the European Parliament and honorary presidential adviser

He added that resumption of sales is estimated for December and that the notices also cover several generics. Voiculescu also accused the PSD of destroying the medicamentelipsa.ro platform he set up as health minister in 2016, which let patients report missing medicines and committed the ministry to assess reports within four working days and communicate measures within seven days. Rasu Miruță, a former USR defence minister in the Bolojan government, posted on Facebook that the same agency document lists a Lyrica 150 mg notice from the manufacturer dated 15 May, with no deliveries from June to December. Miruță said a Lyrica 75 mg notice, announced on 18 September, showed a shortfall from November, and suggested that Rogobete publicly apologise to Ruse.

Brussels meeting and the pharmacy chains

Speaking at a press conference on Sunday, 15 November, Rogobete said:

“There are many molecules, pharmaceutical products, which are in fact in warehouses but are not distributed to pharmacies.”

Alexandru Rogobete, romanian Minister of Health

He said he would meet distributors and European medicine manufacturers in Brussels on Tuesday, 17 November, about products that sit in warehouses without reaching pharmacies. He blamed the growing influence of large pharmacy chains and said a forthcoming legislative change would publish warehouse stock levels on the Ministry of Health website. He also said cheap or low-volume products are often kept off shelves because display costs are not covered by sales, and advised patients to search by active substance rather than brand name.

Ask about this text

Sources and context

Pollar is free and carries no ads in the text. Its members keep it going.

Support Pollar